Hims & Hers planning to sell compounded peptides
Summary
Hims & Hers Health announced plans to start selling compounded peptides. The company is working on creating high-quality peptides made in the U.S., offering expert advice and regular blood tests to customers.Key Facts
- Hims & Hers Health plans to sell compounded peptides.
- Peptides will be made in the United States.
- The company aims to provide expert clinical guidance with the peptides.
- Regular blood testing will be part of the service to monitor customers’ health.
- The announcement was made during the company’s Monday earnings call.
- Andrew Dudum, the CEO, shared these details during the call.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
